MethadoneNCT01270100
Recovery Management Intervention in China
A study testing Recovery management in people with Methadone and HIV Infections, run by University of California, Los Angeles at 1 site in China.
Trial summary
The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China. The project has the following specific aims: Primary aims: Aim 1. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Methadone, HIV Infections
- What is being tested?
- Recovery management
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- Not given
- Where
- 1 siteChina
- Study dates
- Start not givento not given
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Inclusion Criteria:The study population will be drawn from all adult patients at participating compulsory rehabilitation facilities who:
- have been incarcerated for at least one year and would have been eligible for MMT at the time of incarceration,
- have at least 1 month remaining before release,
- met the DSM-IV criteria for heroin dependence at the time of incarceration,
- are willing to enroll in methadone maintenance treatment, and
- are Shanghai residents who reside in the areas of Shanghai targeted by the study.
Exclusion Criteria: Individuals diagnosed with severe mental illness will not be eligible to participate.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Reducing HIV/AIDS and Drug Abuse Among Heroin Addicts Released From Compulsory Rehabilitation in China
The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China.
The project has the following specific aims:
Read more
Primary aims:
Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care.
Secondary aim:
Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors.
It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors
- Conditions
- Methadone, HIV Infections
- Being tested
- Recovery management
- Medical subject headings
- HIV Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Recovery managementBehavioural
| Study group | Role | What they receive |
|---|---|---|
| Recovery management intervention | Experimental | Not described Receives: Behavioral: Recovery management |
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jan 2011 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for MethadoneStudies of the same condition, open and under way.
- More trials run by University of California, Los AngelesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
Sponsor and investigators
- Lead sponsor
- University of California, Los Angeles
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01270100
- Sponsor's protocol ID
- DA025385
- Other IDs
- 1R21DA025385-01
- Status last verified
- Dec 2010
- First submitted
- 4 Jan 2011
- Last updated
- 5 Jan 2011
- Results posted
- No
Publications
Hser YI, Fu L, Wu F, Du J, Zhao M. Pilot trial of a recovery management intervention for heroin addicts released from compulsory rehabilitation in China. J Subst Abuse Treat. 2013 Jan;44(1):78-83. doi: 10.1016/j.jsat.2012.03.009. Epub 2012 Apr 18.
PubMed 22520276
Study at a glance
From the registry record, last updated by the sponsor on 5 Jan 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reducing HIV/AIDS and Drug Abuse Among Heroin Addicts Released From Compulsory Rehabilitation in China
- ClinicalTrials.gov ID
- NCT01270100
- Acronym / sponsor ID
- DA025385
- Conditions
- Methadone, HIV Infections
- Study type
- Interventional
- Recruitment status
- Completed
- Lead sponsor
- University of California, Los AngelesUniversity, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA)
- First posted
- 5 Jan 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to develop and pilot-test a Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China.
The project has the following specific aims:
Primary aims:
Aim 1. To engage key stakeholders in the local communities involved in supporting the transition of heroin addicts released from compulsory rehabilitation to the community; Aim 2. To identify potential barriers for participating in MMT in China; Aim 3. To develop and deliver educational/training materials on HIV risks, relapse prevention, and MMT; Aim 4. To adapt and develop the Recovery Management Intervention (RMI) program for heroin addicts released from compulsory rehabilitation in China; Aim 5. To conduct a pilot trial and obtain preliminary outcome data associated with RMI, relative to enhanced standard care.
Secondary aim:
Aim 6. To explore predictors of relapse and HIV/AIDS risk behaviors.
It is hypothesized that the intervention will reduce drug use relapse and the negative consequences associated with relapse, including HIV risk behaviors
Study design
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Recovery management intervention | Experimental | Behavioral: Recovery management |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Recovery management | Behavioural | Recovery management intervention |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jan 2011.
- Derived from this study: PubMed 22520276Hser YI, Fu L, Wu F, Du J, Zhao M. Pilot trial of a recovery management intervention for heroin addicts released from compulsory rehabilitation in China. J Subst Abuse Treat. 2013 Jan;44(1):78-83. doi: 10.1016/j.jsat.2012.03.009. Epub 2012 Apr 18.
Related trials for Methadone
Not yet recruitingObservational study
Methadone Administration in Critically Ill Patients in the Intensive Care Unit and Risk of Prolonged QTc and Cardiac Arrythmia
Patients Treated With Methadone
Not yet recruiting
Methadone Expansion in Detention Though the Hospital/Clinic Designation
Opioid Use Disorder, Incarcerated Individuals
Enrolling by invitationObservational study
Multimodal Fetal and Placental Imaging and Biomarkers of Clinical Outcomes in Opioid Use Disorder
Opioid Use Disorder, Substance-Related Disorders
RecruitingPhase 2/3
Divided or Single Exposure (DOSE) Study
Opioid Use Disorder, Chronic Pain
Not yet recruitingObservational study
Methadone Dose Monitoring With a Remote Medication Monitor
Methadone Toxicity, Methadone Overdose
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Recovery management in people with Methadone and HIV Infections, run by University of California, Los Angeles at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jan 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01270100, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2011; AzTrials last refreshed its copy on 29 Oct 2026.